Neurocognitive effects of aripiprazole in adolescents and young adults with schizophrenia

References

• Stip E, Tourjman V. Aripiprazole in schizophrenia and schizoaffective disorder: A review. Clin Ther 2010;32 Suppl A:S3–20.
   Google Scholar
• Sims A. Symptoms in the mind: An introduction to descriptive psychopathology. Philadelphia, PA: W. B. Saunders; 2002.
   Google Scholar
• Findling RL, Kauffman RE, Sallee FR, Carson WH, Nyilas M, Mallikaarjun S, et al. Tolerability and pharmacokinetics of aripiprazole in children and adolescents with psychiatric disorders. J Clin Psychopharmacol 2008;28:441–6.
   PubMed Web of Science ®Google Scholar
• Findling RL, Robb A, Nyilas M, Forbes RA, Jin N, Ivanova S, Marcus R, et al. A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia. Am J Psychiatry 2008;165: 1432–41.
   PubMed Web of Science ®Google Scholar
• Swainston HT, Perry CM. Aripiprazole: A review of use in schizophrenia and schizoaffective disorder. Drugs 2004;64: 1715–36.
   PubMed Web of Science ®Google Scholar
• Meltzer HY, Sumiyoshi T. Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia?Behav Brain Res 2008;195:98–102.
   PubMed Web of Science ®Google Scholar
• Newman-Tancredi A. The importance of 5-HT1A receptor agonism in antipsychotic drug action: Rationale and perspectives. Cur Opi Investig Drugs 2010;11:802–12.
   PubMed Web of Science ®Google Scholar
• Pringsheim T, Lam D, Ching H, Patten S. Metabolic and neurological complications of second-generation antipsychotic use in children: A systematic review and meta-analysis of randomized controlled trials. Drug Saf 2011;34:651–8.
   PubMed Web of Science ®Google Scholar
• Conners KC. Conners’ Continuous Performance Test II: Computer program for Windows technical guide and software manual. North Tonawanda, NY: Multi-Health Systems; 2004.
   Google Scholar
• Chen KC, Chu CL, Yang YK, Yeh TL, Lee IH, Chen PS, et al. The relationship among insight, cognitive function of patients with schizophrenia and their relatives’ perception. Psychiatry Cli Neurosci 2005;59:657–60.
   PubMed Web of Science ®Google Scholar
• Heaton RK, Talley JL, Kay GG et al. Wisconsin Card Sorting Test Manual. Odessa, NY: Psychological Assessment Resources; 1993.
   Google Scholar
• Stuss DT, Levine B, Alexander MP, Hong J, Palumbo C, Hamer L, Murphy KJ, et al. Wisconsin Card Sorting Test performance in patients with focal frontal and posterior brain damage: Effects of lesion location and test structure on separable cognitive processes. Neuropsychologia 2000;38:388–402.
   PubMed Web of Science ®Google Scholar
• Kern RS, Green MF, Cornblatt BA, Owen JR, McQuade RD, Carson WH, et al. The neurocognitive effects of aripiprazole: An open-label comparison with olanzapine. Psychopharmacology (Berl) 2006;187:312–20.
   PubMed Web of Science ®Google Scholar
• Riedel M, Spellmann I, Schennach-Wolff R, Musil R, Dehning S, Cerovecki A, et al. Effects of aripiprazole on cognition in the treatment of patients with schizophrenia. Pharmacopsychiatry 2010;43:50–7.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Gen K, Inoue Y. An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia. Prog Neuropsychopharmacol Bio Psychiatry 2011;35:161–8.
   Google Scholar
• Lee HY, Ham BJ, Kang RH, Paik JW, Hahn SW, Lee MS, et al. Trial of aripiprazole in the treatment of first-episode schizophrenia. Psychiatry Clin Neurosci 2010;64:38–43.
   PubMed Web of Science ®Google Scholar
• Fleck DE, Shear PK, Madore M, Strakowski SM. Wisconsin Card Sorting Test performance in bipolar disorder: Effects of mood state and early course. Bipolar Disord 2008;10:539–45.
   Google Scholar
• Mentzel H-J, Gaser C, Volz H-P, Rzanny R, Häger F, Sauer H, et al. Cognitive stimulation with the Wisconsin Cart Sorting Test: Functional MR imaging at 1.5T. Radiology 1998;207: 399–404.
   PubMed Web of Science ®Google Scholar
• Sax KW, Strakowski SM, Zimmerman ME, DelBello MP, Keck PE Jr, Hawkins JM. Frontosubcortical neuroanatomy and the continuous performance test in mania. Am J Psychiatry 1999;156:139–41.
   PubMed Web of Science ®Google Scholar
• Axelrod BN, Goldman RS, Heaton RK, Curtiss G, Thompson LL, Chelune GJ, et al. Discriminability of the Wisconsin Card Sorting Test using the standardization sample. Clin Exp Neuropsychol 1996;18:338–42.
   PubMed Web of Science ®Google Scholar
• Meyer SE, Carlson GA, Wiggs EA, Martinez PE, Ronsaville DS, Klimes-Dougan B, et al. A prospective study of the association among impaired executive functioning, childhood attentional problems, and the development of bipolar disorder. Dev Psychopathol 2004;16:461–76.
   PubMed Web of Science ®Google Scholar
• Frangou S, Haldane M, Roddy D, Kumari V. Evidence for deficit in tasks of ventral, but not dorsal, prefrontal executive function as an endophenotypic marker for bipolar disorder. Bio Psychiatry 2005;58:838–9.
   PubMed Web of Science ®Google Scholar
• Barcelo F, Knight R. Both random and perseverative errors underlie WCST deficits in prefrontal patients. Neuropsychologia 2002;40:349–56.
   PubMed Web of Science ®Google Scholar
• Nyhus E, Barceló F. The Wisconsin Card Sorting Test and the cognitive assessment of prefrontal executive functions: A critical update. Brain Cogn 2009;71:437–51.
   PubMed Web of Science ®Google Scholar
• Makkos Z, Fejes L, Inczédy-Farkas G, Kassai-Farkas A, Faludi G, Lazary J. Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:212–7.
   PubMed Web of Science ®Google Scholar